AKBM — Aker Biomarine ASA Share News
0.000.00%
Last trade - 00:00- NOK8.68bn
- NOK10.43bn
- $218.10m
Brief: Krill Oil Receives Approval Of Health Claim In Australia
Brief: Aker Biomarine Receives Approval For Lysovetatm As New Dietary Ingredient In The US
Brief: Aker BioMarine Q2 Adjusted EBITDA USD 21.5 Million
Brief: Aker Biomarine Gets Receipt Of Approval Of Superba Krill Oil In Korean Market
Brief: Aion Enters Collaboration With Microsoft Norway
Brief: Aker Biomarine Expects Long-Term Average Annual Sales Growth At Around 15%
Brief: Aker BioMarine Q1 Adj. EBITDA at USD 6 Million
Brief: Aker Biomarine Expects South Korea To Approve Superba Krill Oil
Brief: Company Related To Aker Biomarine Chairman Buys Shares
Brief: Aker BioMarine Q4 Revenue Misses Analyst Expectations
Brief: Aker Biomarine Product Mainly Containing Superba Krill Oil Is Approved In South Korea
Brief: Aker Biomarine Enters Into Partnership With Chinese Pet Food Brand
Brief: Aker Biomarine Q3 Adj. EBITDA Up At $19 Mln
Brief: Aker Biomarine Updates On Krill Harvesting For 2022
Brief: Aker Biomarine Signs First Commercial Agreement Signed For Lysoveta
Brief: Aker Biomarine Q2 Adjusted EBITDA USD 21 Million, Up 11% y-o-y
Brief: Aker Biomarine Secures FDA Approval For QRILL Aqua In US
Brief: Ocean 14 Capital, Aker Biomarine Provide AION With NOK 40 Mln Convertible Loan Facility
Brief: Aker Biomarine Q1 Adjusted EBITDA At USD 8.1 Million